# DDLS 2026 — Week 2 interview transcript

**Lab:** Interview an Image Data Owner
**Data owner:** Dr. Yasmin Haque — Clinical microscopist, malaria diagnostics
**Student:** nazlia <nazlia@kth.se>
**Exported:** 2026-09-02T11:40:11+00:00

> This is the record of your interview with the data owner. Hand it to your analyst agent as the raw source for `AGENTS.md` and `spec.md`.

---

**You**:

what are you trying to find out and what is expected from this?

**Dr. Yasmin Haque**:

I’m Dr Yasmin Haque, a clinical microscopist at MORU in Bangkok. These are 2,387 individual red-cell pictures cut from thin smears belonging to 24 patients. I need to know whether malaria-positive patient slides have a clearly higher share of infected cells than malaria-free slides, so we can write one simple rule for flagging a slide for human review—using every cell, without calling the share a patient’s clinical parasitemia. What are you planning to compare first: the individual cells or the slides patient by patient?

**You**:

how do you want me to solve this?

**Dr. Yasmin Haque**:

That’s your side of it—I know the films, not the machinery. Work patient by patient: use every cell on each of the 24 slides, compare the infected-cell share for the 16 malaria slides with the 8 malaria-free slides, and give me one plain yes/no rule with the numbers supporting it. Do not present that share as clinical parasitemia, and make sure a slide with only faint early rings is sent for checking rather than dismissed. Will you report one value for each patient slide, rather than pooling all 2,387 cells together?

**You**:

yes, I will try!

**Dr. Yasmin Haque**:

Good. Keep the patient slides separate, and remember the share is a screening measure from these cropped cells—not a clinical parasitemia measurement. The faint rings are the ones I worry about most.

**You**:

what happens once you know?

**Dr. Yasmin Haque**:

If the slide groups separate clearly, I’ll record a simple rule: slides above the chosen infected-cell share go to a microscopist, and the others may be set aside only if faint infections are still protected. If they do not separate clearly, we do not put that rule into the protocol; a human reads the slides. Are you planning to show me the 24 slide-level shares alongside the proposed cut-off?

**You**:

what is the most important part of this? what is the main purpose?

**Dr. Yasmin Haque**:

The main purpose is to decide whether a patient slide can be safely flagged from the proportion of infected cells, so obvious clean slides can be set aside and suspicious ones sent to a microscopist. The most important part is not missing a slide with a faint early infection; a screening rule that quietly dismisses those is no use to me. Are you treating the slide—not the individual cell—as the unit of the decision?

**You**:

so tell me a little more about the images. for example what do they display

**Dr. Yasmin Haque**:

They are ordinary colour microscope photographs, each cropped to one red blood cell from a Giemsa-stained thin blood film. Some show malaria inside the cell—a deep-purple chromatin dot with a pale bluish ring, or occasionally a larger form—and the rest are clean pinkish-grey cells. There are 2,387 pictures altogether: 956 infected and 1,431 clean, from 24 patient slides. Are you asking next about how the infected cells look, or about how the pictures are grouped by patient?

**You**:

both

**Dr. Yasmin Haque**:

The infected cells show a small deep-purple chromatin dot with a paler bluish ring inside the red cell; later forms can look like a larger purple blob. Clean cells are even pinkish-grey discs without anything inside. Here is the side-by-side plate:

![Top row: parasitized cells; bottom row: clean uninfected cells.](/week/2/img/example_cells.png)

The 2,387 crops come from 24 patient slides: 16 patients had malaria and 8 had none. Each crop carries its slide tag, and the infected slides vary greatly—from heavily involved to just one or two faint rings among many clean cells. Do you want to examine the appearance of the misleading purple stain and debris next?

**You**:

yes

**Dr. Yasmin Haque**:

The misleading marks are dark-purple stain clumps, dust or debris, and sometimes a platelet lying on top of the red cell. They can look very much like a parasite, but they lack the delicate ring and proper position inside the cell. The faint early rings are the opposite problem: genuine parasites, but so pale that a tired reader can pass them by. Are you planning to check how often these look-alikes occur on each patient slide?

**You**:

yes

**Dr. Yasmin Haque**:

Good—keep those counts separate for each patient slide, rather than treating all purple marks alike. I have the cell labels, but I do not have a separate tally of stain clumps, debris, or platelets; that distinction needs checking at the scope. Will you record the infected-cell share for every slide as well?

**You**:

I hope I will

**Dr. Yasmin Haque**:

You’ll need to—otherwise we learn about pictures, not patients. For each slide, count the infected cells and all cells, then report the share and whether the patient slide was malaria-positive or malaria-free. Can you confirm you’ll keep the eight malaria-free slides in the comparison too?

**You**:

yes

**Dr. Yasmin Haque**:

Good. Keep those eight slides in; they are the clean comparison group, with no infected cells. The useful result will be 24 slide-level shares, not one grand share for all 2,387 cells. Will your final rule send any slide above its chosen cut-off for microscopist review?

**You**:

yes

**Dr. Yasmin Haque**:

That is the right shape of decision: one share per patient slide, then a simple review rule. Keep the cut-off low enough that a lightly infected slide is not quietly set aside. What numbers will you use to justify where you place it?

**You**:

I need more information about the images, the more technical information such as modality and stain, pixel size and magnification, the object to find, file format, bit depth and length, channels, dimensions, how many. I also want you to provide some example images and point out what I am looking at

**Dr. Yasmin Haque**:

What I can confirm from the set:

- **Image type:** ordinary colour photographs of Giemsa-stained thin blood films, taken through a microscope.
- **Stain:** Giemsa.
- **Object:** one cropped red blood cell per picture, with blackened corners outside the cell.
- **What to find:** an intra-cellular malaria parasite—usually a deep-purple chromatin dot with a paler bluish ring; larger purple forms occur too.
- **Clean appearance:** an even pinkish-grey disc with no parasite inside.
- **Number:** 2,387 cell pictures—956 marked infected and 1,431 clean.
- **Patient grouping:** 24 slides: 16 from patients with malaria and 8 from patients without it.
- **Pixel dimensions:** not uniform; the crops were made to the cell, so I do not have one fixed width and height.
- **Magnification, file format, bit depth, exact channel arrangement, and file size:** I was not given those details, and I will not invent them. That is metadata from the image files, not something I can reliably tell at the scope.

Here is an infected cell: the purple ring form is near the edge of the red cell.

![Parasitized red blood cell with a ring form.](/week/2/img/parasitized_ring.png)

And here is a clean cell:

![Uninfected red blood cell.](/week/2/img/uninfected_cell.png)

For the side-by-side examples, the **top row contains parasitized cells**—look for the purple material inside the cell—and the **bottom row contains clean cells**:

![Top row: parasitized cells; bottom row: clean uninfected cells.](/week/2/img/example_cells.png)

One caution from the microscope: a dark-purple stain clump, dust particle, or platelet can imitate the parasite, while a genuine early ring can be extremely faint. Can you inspect the files’ metadata for the missing technical details rather than assuming them?

**You**:

of course

**Dr. Yasmin Haque**:

Good. The file metadata is the proper place to get dimensions, channels, bit depth, format, and magnification—not my microscope notes. I can vouch for the Giemsa film, the one-cell crops, and the slide grouping; you can vouch for the file properties.

**You**:

is there anything more you wish to tell me about the images, or do you want to show me anything else regarding this topic?

**Dr. Yasmin Haque**:

One more point: these are cropped cells, not complete microscope fields, and the crops vary in size; some clip the cell edge or include a neighbour, with black corners outside the cell. The stain also took more heavily on some slides, so purple alone is not enough—look for a parasite’s position and ring form. I have already shown the useful examples; what I would want to see from you now is the 24 patient-slide shares beside their malaria status.

**You**:

okay, perfect

**Dr. Yasmin Haque**:

Right. Then keep the calculation at the patient-slide level and use all cells on each slide. I’ll be looking for a plain review rule supported by the 24 slide shares, with faint infections protected rather than dismissed.

**You**:

can you tell me a bit about the microscope and what kind you are using to extract these images, and some technical information about them

**Dr. Yasmin Haque**:

I can only confirm that these are ordinary colour photographs taken through a microscope from Giemsa-stained thin blood films; I was not given the microscope make or model, objective, eyepiece, camera, illumination, or calibration. The cells were cut out of the photographs afterward by software—the microscope did not produce one-cell images directly. Can you inspect the original image files or collection record for the instrument and acquisition details?

**You**:

was it a confocal microscope?

**Dr. Yasmin Haque**:

No, not confocal. These are ordinary bright-field colour photographs of Giemsa-stained thin blood films, cropped afterward into one-cell pictures. I don’t have the make, objective, or camera details.

**You**:

okay, so just a regular bright-field microscope. got it

**Dr. Yasmin Haque**:

Yes—ordinary bright-field microscopy, with the Giemsa stain providing the colour and contrast. The exact instrument settings are not recorded in the information I have.

**You**:

are there any traps that I should keep in mind?

**Dr. Yasmin Haque**:

Yes. The main traps are:

- Do not pool all 2,387 cells; compare the 24 patient slides separately.
- Count every cell on a slide, including clean ones, and do not call the resulting share clinical parasitemia.
- Purple stain clumps, dust, debris, and platelets can imitate parasites.
- Faint early rings are genuine infections and must not be dismissed simply because the share is small.
- Crop sizes, clipped cells, black corners, and staining differences can make slides look unlike one another.

Will you state plainly how your rule handles a slide containing only one or two faint infected cells?

**You**:

yes

**Dr. Yasmin Haque**:

Good. Then a slide with even one or two convincing faint rings should be sent for human review, not set aside because its infected-cell share is small. At the scope, those early rings are precisely what a tired reader can miss. Have you written that exception into your proposed rule?

**You**:

should I keep something in mind, such as the out-of-focus and uneven illumination, staining/batch variation between images, class imbalance (rare objects), touching or overlapping objects, debris and artifacts,  what they trust least, etc.?

**Dr. Yasmin Haque**:

Yes. I trust a dark-purple speck least when it has no clear ring or sits on the cell surface—it may be stain, dust, debris, or a platelet. Be wary of blurred cells, uneven lighting, heavy or pale staining, clipped edges, and a neighbouring cell intruding; genuine rings can be faint, while some slides contain very few infected cells among many clean ones. Which of these are you planning to mark for human review rather than allow the rule to dismiss?

**You**:

give me some more and in depth information

**Dr. Yasmin Haque**:

At the scope, I would be most cautious with **blurred or poorly lit cells**. A faint ring may disappear in an out-of-focus crop, while glare, uneven illumination, or a heavy stain can make an ordinary mark look important. A dark purple mark is not enough: I want to see it sitting within the red cell, with the appearance of parasite cytoplasm and a chromatin dot—not simply stuck on the surface or lying at the edge.

The staining matters because the slides were not all treated identically. On a heavily stained film, clumps and platelets become conspicuous; on a pale film, a real early ring may be barely visible. That means a small infected-cell share on one slide should not be treated as directly equivalent to the same share on another without looking at the film quality. The crops also sometimes clip the red cell or include a neighbour, so an apparent mark may belong to something outside the cell being judged.

There are many more clean cells than infected ones—1,431 clean pictures against 956 infected—but the important clinical problem is not that the infected ones are uncommon in the file. It is that a malaria-positive patient can have only a handful of infected cells among a great many healthy ones. A rule based only on how many obvious purple cells appear could therefore quietly dismiss the lightly infected patient. The eight malaria-free slides are useful because they contain no marked infected cells, but purple debris on those slides may still resemble malaria to an inexperienced reader.

I trust **a clear ring with a chromatin dot inside an intact cell** most. I trust **isolated purple colour without structure, marks at a clipped edge, and anything in a blurred or unevenly lit crop** least. For the protocol, I would want such doubtful slides kept for a microscopist rather than treated as safely clean. Can you show me how you intend to record image quality and doubtful marks separately from the infected-cell share?

**You**:

can you give me all the necessary data for this

**Dr. Yasmin Haque**:

I can give you the specimen information and labels I know; I cannot invent the file metadata.

**Confirmed from the collection**

- **Material:** Giemsa-stained thin blood films.
- **Microscopy:** ordinary bright-field colour microscopy, not confocal.
- **Images:** 2,387 cropped pictures, one red blood cell per picture.
- **Cell labels:** 956 parasitized and 1,431 uninfected.
- **Patient slides:** 24 in total—16 from malaria-positive patients and 8 from patients without malaria.
- **Grouping:** every cell picture has a slide tag, so the cells can be returned to their patient slide.
- **Positive appearance:** usually a deep-purple chromatin dot with a paler bluish ring inside the red cell; some are larger forms or contain more than one parasite.
- **Clean appearance:** an even pinkish-grey red-cell disc.
- **Crop appearance:** variable width and height; black corners outside the cell; some crops clip the cell edge or include part of a neighbour.
- **Known troublesome appearances:** stain clumps, dust, debris, and platelets can resemble parasites; faint early rings can be missed.
- **Slide variation:** staining strength and image quality vary between slides.

**Not recorded in my notes**

I do not know the exact microscope make or model, objective magnification, camera, pixel scale, illumination settings, file format, bit depth, channel arrangement, individual pixel dimensions, file lengths, or whether any pictures are out of focus. Those must be read from the files and the original collection record.

For the comparison you need, retain the image filename, slide tag, cell label, and—if you inspect them—whether the crop is blurred, clipped, unevenly lit, or contains a possible stain/debris mark. The final comparison must use each slide’s infected-cell share, not one share for all 2,387 pictures, and it must not be reported as a patient’s clinical parasitemia. Do you want me to separate this into a data table you need from the files and observations that require a microscopist?

**You**:

do you have any other data or numbers that you haven't mentioned that are important for this to work?

**Dr. Yasmin Haque**:

Yes—the important numbers I have **not** given are the counts for each individual slide: how many cell pictures came from each of the 24 patients, and how many of those were marked infected. Without those 24 pairs of counts, you cannot compare the malaria-positive and malaria-free slides or choose a review cut-off; the totals of 956 and 1,431 alone are not enough. You also need the slide tag and malaria status attached to each cell, plus a note for blurred, clipped, poorly lit, or doubtful crops if you want to know where the pictures are least trustworthy.

I do not have the per-slide counts, their smallest and largest values, or the slide-by-slide infected-cell shares in my notes. At the scope, the most important missing information is whether the few infected cells on a lightly infected patient are faint rings or merely doubtful purple material. Can you extract the slide-level counts from the labels and show me those 24 rows?

**You**:

yes

**Dr. Yasmin Haque**:

Good. Then make one row per patient slide with its total cell count, infected-cell count, resulting share, and malaria status. Keep doubtful marks and poor-quality crops noted separately; they should not be silently folded into the infected count. Which slide has the smallest infected-cell share among the 16 malaria-positive patients?

**You**:

so the quality-control annotations are undefined, so how to blur, clipping, illumination, staining, neighbor's, and doubtful artifacts will be recorded and kept separate from infection labels

**Dr. Yasmin Haque**:

Correct: those quality notes are **not already defined in the set**. I would keep them as separate observations for each crop, alongside—not replacing—the infection mark:

- **Focus:** clear / blurred / uncertain  
- **Cell boundary:** intact / clipped  
- **Lighting:** even / uneven or glare  
- **Stain:** ordinary / unusually pale or heavy  
- **Neighbour:** absent / part of another cell intrudes  
- **Artifact:** none / debris, dust, clump, or platelet suspected  
- **Microscopist confidence:** clear / doubtful  

The original infection mark must remain unchanged: infected, clean, or—if the expert review permits it—uncertain. A quality note should never turn a clean cell into an infected one, or hide a faint ring; it tells you which pictures deserve another look and which slide shares are being supported by unreliable crops. Do you want those notes made for every crop, or only for crops that are blurred, clipped, or doubtful at the scope?

**You**:

what would you define as done?

**Dr. Yasmin Haque**:

I would call it **done** when:

- all **2,387 cell pictures** are assigned to one of the **24 patient slides**;
- each slide has its total cell count, infected-cell count, infected-cell share, and malaria status;
- the slide counts add back to **956 infected** and **1,431 clean** cells;
- the **16 malaria slides** are compared separately with the **8 malaria-free slides**;
- blur, clipped edges, uneven light, heavy staining, neighbouring cells, and suspected debris are recorded separately from the infection mark;
- a simple cut-off is chosen for sending a slide to a microscopist, with a slide containing even one or two convincing faint rings still sent for review;
- the report calls the number an **infected-cell share in these cropped images**, never the patient’s clinical parasitemia.

I would not call it done from the two overall cell totals alone, because they say nothing about how the infected cells are spread across patients. Do you have the 24 slide-level counts yet?

**You**:

answer this: classify, segment, count or defect? what does a good answer look like, whether ground-truth labels/masks exist, the decision it feeds, format, what would make it useless?

**Dr. Yasmin Haque**:

For this set, the useful task is **counting infected cells per patient slide**, using every cell on that slide. Each crop already has an expert mark—**parasitized or clean**—but there are **no pixel-by-pixel parasite outlines**, so this is not a task for tracing the parasite’s exact shape. Image-quality problems—blur, clipping, uneven light, stain, neighbours, and debris—should be separate notes, not infection marks.

A good result would give, for each of the **24 slides**, the slide tag, total cells, infected-cell count, infected-cell share, and malaria status, then use a plain rule to send suspicious slides to a microscopist. I do not know the file format or exact label-file format; the files and collection record must establish that. It becomes useless if it pools all 2,387 crops, ignores clean cells, treats the share as clinical parasitemia, loses the slide tags, or dismisses a lightly infected slide because only one or two faint rings are present. Will you use the existing expert cell marks as the reference labels and keep the quality notes in separate columns?

**You**:

is there any more information regarding all this that you have mentioned that you feel like you want to specify, go into depth with? is there anything you think that you have missed?

**Dr. Yasmin Haque**:

Yes. The key distinction is this:

- **At the picture level**, each crop is marked **infected** or **clean**. That is a two-way cell reading task.
- **At the patient level**, the useful output is the **number infected out of all cells examined on that slide**, plus whether the slide should go to a microscopist.
- **Segmentation is not supported**: there are no outlines showing the parasite’s exact pixels, only the cell-level mark.
- **Defect detection is not the purpose**. Blur, dust, stain clumps, clipped edges, uneven light, and neighbouring cells are quality concerns to record separately.

The expert marks are the reference reading for these crops, but they are not a substitute for a complete clinical film examination. The pictures are one-cell crops from thin films, and the 956 infected and 1,431 clean marks describe this collection—not a patient’s exact parasite burden. I would call the resulting number an **infected-cell share among the photographed crops** and nothing stronger.

The patient-slide tag is essential. If it is lost, the work becomes much less useful, because a large number of infected crops from one heavily infected patient could hide a lightly infected patient. The eight malaria-free slides must remain visible in the comparison, and every clean cell must remain in the count. A result that reports only the 956 infected pictures, or one overall percentage for all 2,387, would not answer the programme’s question.

The quality notes also need fixed meanings before anyone records them. For example, “blurred” should mean that the parasite or cell boundary cannot be read confidently; “clipped” means the cell is cut by the crop; “neighbour” means material from another cell could be mistaken for the target cell’s contents; and “doubtful artifact” means stain, dust, debris, or a platelet is more plausible than malaria. Those notes should not alter the original infected/clean mark. They tell you which readings are fragile and which pictures should be checked by a person.

What I still do **not** know is the per-slide cell counts, the exact file and label formats, the microscope and camera details, or whether there are duplicate pictures or unusable files. Without the 24 slide rows, there is no defensible plain rule. The result becomes useless if it quietly treats faint rings as clean, treats purple colour alone as infection, or presents the crop share as clinical parasitemia. Do you want the final specification written as a compact table of required fields and allowed values?

**You**:

is there anything more that you feel like you want or need to mention to me so that I can complete this task correctly?

**Dr. Yasmin Haque**:

One thing I would insist on: do not silently remove poor-quality crops from the slide count. Keep every photographed cell in the slide’s total, record its quality concern separately, and report any genuinely missing or unreadable file rather than hiding it. Present the result for each patient slide—infected count, all-cell count, and infected-cell share—with the 16 malaria slides and 8 malaria-free slides clearly identified; call it an **infected-cell share in these crops**, not clinical parasitemia. Any slide with a convincing ring, even only one, should go to a microscopist, while a purple mark without parasite structure should remain doubtful rather than being accepted automatically. Do you have enough information now to write the 24-row slide summary without inventing any microscope or file details?

**You**:

is there anything more you would like to mention?

**Dr. Yasmin Haque**:

Only this: keep the **patient slide** as the unit of the final decision, and preserve the original cell labels and slide tags so every count can be checked back to its crop. Do not choose a rule from the overall 2,387-cell total; that can make a heavily infected slide look reassuring while a lightly infected patient is missed. The final wording should say **“infected-cell share among photographed crops”**, with doubtful or poor-quality images reported separately.

**You**:

the 24 slide-level counts and malaria-status mapping are still missing, including the smalest and largest slide totals and infected-cell shares

**Dr. Yasmin Haque**:

Yes—that information is missing from what I was given. I know only the overall totals: **2,387 cells**, with **956 infected** and **1,431 clean**, across **24 slides**—**16 malaria-positive and 8 malaria-free**. I cannot give the smallest or largest slide totals, or the smallest and largest infected-cell shares, without the individual slide tags and labels; those must be read from the files.

**You**:

so data integrity and provenance remain partly uncovered, duplicate crops, missing or unreadable files, label assignment process, collection dates, and any prior filtering or exclusions

**Dr. Yasmin Haque**:

Correct. I know the crops were marked cell by cell by an expert and carry slide tags, but I do **not** know whether any crops were duplicated, lost, unreadable, or removed before I received them. I also lack the collection dates, the exact label-review procedure, and a record of any earlier exclusions or corrections; those should be recorded rather than guessed. Can you obtain the original file manifest and the label-generation or review notes?

**You**:

collection dates, slide/patient linkage, samling process, and any batch or source differences remain uncovored

**Dr. Yasmin Haque**:

Yes, those details remain uncovered. I know there are **24 patient slides**, that each crop has a slide tag, and that **16 patients had malaria while 8 did not**; I do not know the collection dates, whether the tags link securely to patient records, how the slides were selected, or whether they came from different sites, staining runs, operators, or batches. Those details matter because a difference between slides may reflect staining or collection conditions rather than malaria. Can you obtain the specimen register and slide-preparation log?

**You**:

label provenance is still incomplete, who  assigned and reviewed infected/clean marks, when, using what criteria, and how disagreements or uncertain cases were handled

**Dr. Yasmin Haque**:

Yes, that remains incomplete. I know an expert marked the 2,387 crops cell by cell as infected or clean, but I do not know their name or qualifications, the dates of reading, whether a second microscopist checked the marks, the written criteria used, or how disagreements and doubtful faint rings were settled. Do not describe the marks as independently confirmed unless the review records show that; obtain the reader log, marking instructions, revisions, and any list of uncertain or adjudicated crops.

**You**:

the slide-level counts, infected cell shares, and malaria status mapping are still missing from the files or labeles

**Dr. Yasmin Haque**:

Yes. I only know the overall figures—**2,387 crops: 956 infected and 1,431 clean; 24 slides: 16 malaria-positive and 8 malaria-free**. The individual slide totals, infected counts, infected-cell shares, and which slide belongs to which status are not in my records, so they cannot be reconstructed honestly without the slide tags and label file. You need a file or table linking each crop to its slide, its infected/clean mark, and the slide’s malaria status.

**You**:

the final objective and decision rule need playback and confirmation, slide level and infected cell shares, separate quality flags and human reviews for any convincing faint ring rather than clinical parasitemia

**Dr. Yasmin Haque**:

Confirmed. The objective is to compare the **infected-cell share for each patient slide**, using every photographed cell, between the **16 malaria-positive** and **8 malaria-free** slides—not to report clinical parasitemia. Quality flags stay separate, and **any slide with even one convincing faint ring goes to human review**; the remaining numerical cut-off cannot be confirmed until the 24 slide-level counts and status mapping are recovered. Can you obtain those rows before choosing the final yes/no rule?

**You**:

play back the entire project with everything that you have given me

**Dr. Yasmin Haque**:

Here is the project as it stands.

### Material

- **2,387 single-cell photographs** from Giemsa-stained thin blood films.
- **956 marked infected** and **1,431 marked clean**.
- Cells come from **24 patient slides**:
  - **16 patients with malaria**
  - **8 patients without malaria**
- Each crop is linked to a slide tag, but the slide-by-slide counts and status mapping are not currently available.
- Crops vary in size, with black corners outside the cell; some clip the cell edge or include part of a neighbour.
- The photographs are ordinary colour bright-field microscope images. Exact microscope, camera, magnification, file format, and illumination settings are not recorded in my notes.
- There are cell-level infected/clean marks, but **no pixel-by-pixel parasite outlines**, so this is not an exercise in tracing parasite boundaries.

### What the reading is meant to support

The decision concerns the **patient slide**, not an anonymous individual cell. For each slide, calculate the number of marked infected cells out of **all photographed cells on that slide**, including the clean ones. Call that result the:

> **infected-cell share among photographed crops**

Do **not** call it the patient’s clinical parasitemia. It is only a share from these cropped photographs.

The final comparison should show the 16 malaria slides separately from the 8 malaria-free slides. It should not pool all 2,387 crops into one overall figure.

### What a finished result should contain

One row for each of the 24 slides:

- slide tag;
- malaria status;
- total photographed cells;
- infected-cell count;
- clean-cell count;
- infected-cell share;
- number of crops with quality concerns;
- number of doubtful readings sent for human review.

The counts should add back to **956 infected** and **1,431 clean**. The smallest and largest slide totals, and the smallest and largest infected-cell shares, still have to be obtained from the files.

### Decision rule

The rule must leave lightly infected slides for a microscopist. A slide with **one or two convincing faint rings** must be sent for human review rather than dismissed because its infected-cell share is small.

I have not been given enough slide-level information to confirm a further numerical cut-off honestly. Any cut-off must be chosen only after the 24 slide rows and their malaria status are recovered. A purple mark without a convincing parasite structure should remain doubtful, not automatically become an infected cell.

### Separate quality observations

Blur, clipped cell edges, uneven lighting, heavy or pale staining, neighbouring cells, debris, dust, stain clumps, and possible platelets should be recorded separately from the infected/clean mark. They should not silently remove a crop from the slide total or change its infection mark.

The marks I trust most are clear ring forms with a chromatin dot inside the red cell. I trust isolated purple colour, surface marks, edge marks, blurred crops, and material that may belong to a neighbour least.

### Information still missing

The following cannot be claimed from my records:

- the 24 slide-level totals and infected counts;
- the infected-cell share for each slide;
- the slide-to-malaria-status mapping;
- duplicate crops;
- missing or unreadable files;
- collection dates;
- secure patient-to-slide linkage;
- how slides were sampled;
- different collection sites, staining runs, operators, or batches;
- who assigned and reviewed the infected/clean marks;
- the reading dates and written criteria;
- how disagreements or uncertain faint rings were resolved;
- any previous filtering, exclusions, corrections, or discarded files.

I know only that an expert marked the crops cell by cell. I cannot call those marks independently confirmed without the review records. The project is therefore defined, but the final comparison and numerical rule are **not yet defensible** until those missing records are recovered. Can you now obtain the crop manifest, slide-tag table, and original marking records?

**You**:

and lastly, what is it exactly you want me to find out

**Dr. Yasmin Haque**:

I want you to find out whether a **patient slide can be safely triaged from the infected-cell share among all its photographed cells**.

To do that, recover:

1. The **24 slide-level rows**: slide tag, malaria status, total cells, infected cells, clean cells, and infected-cell share.
2. The smallest and largest slide totals and shares, with the 16 malaria-positive and 8 malaria-free slides kept separate.
3. Whether any crops are duplicated, missing, unreadable, previously excluded, or corrected.
4. How the slide and patient links were established, including collection dates, source sites, staining batches, and operators.
5. Who assigned and reviewed the infected/clean marks, under what criteria, and how faint or disputed cases were handled.
6. Separate quality notes for blur, clipping, illumination, staining, neighbours, debris, and other doubtful artefacts.

Then state one plain **positive-slide rule**: a slide is sent for human review if its infected-cell share warrants concern, with an explicit override that **any convincing faint ring is enough for review**. Report the share as a property of these photographed cells—not as the patient’s clinical parasitemia.
